The Recombinant Aeromonas salmonicida Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE is a membrane protein classified in chemical databases with the specific identifier CB815628356 . This protein belongs to a class of membrane transporters known as flippases, which facilitate the translocation of lipid-linked substrates across cellular membranes. The specific function of this protein involves the movement of 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol molecules across the bacterial membrane, a process critical for lipopolysaccharide (LPS) modification in many Gram-negative bacteria.
Commercial preparations of this recombinant protein are available through suppliers such as CUSABIO TECHNOLOGY LLC, indicating its relevance to current research applications . The protein is typically produced through recombinant expression systems, with options including production in E. coli, yeast, baculovirus, or mammalian cell expression systems . This flexibility in production methodologies allows researchers to select the most appropriate system for their specific experimental requirements.
While the specific molecular weight of the native ArnE protein from Aeromonas salmonicida is not definitively established in the available literature, the protein is characterized as a membrane-embedded flippase component. The protein's nomenclature indicates its predicted function in flipping phosphoundecaprenol-linked substrates across the bacterial membrane, specifically those containing the modified arabinose component 4-amino-4-deoxy-L-arabinose.
Commercially available recombinant forms of this protein (product code VAng-Lsx1517) are prepared specifically for research applications, with documentation emphasizing that these preparations are strictly for research purposes and cannot be used directly on humans or animals . This restriction underscores the preliminary nature of research involving this protein and its current application primarily in basic science investigations.
To understand the significance of the ArnE protein, it is essential to examine the biological context of Aeromonas salmonicida, the bacterium from which this protein originates. Aeromonas salmonicida is a Gram-negative, facultative anaerobic, rod-shaped bacterium belonging to the family Enterobacteriaceae . This pathogen is most notably recognized as the etiological agent of furunculosis, a severe septicemic disease affecting salmonids and other teleost species worldwide .
Furunculosis manifests with distinctive clinical presentations, including characteristic skin lesions referred to as furuncles, ulcers, exophthalmia, hemorrhages, and systemic septicemia, often resulting in acute mortality in affected fish populations . The economic impact of this disease on aquaculture operations is substantial, making understanding the pathogenesis mechanisms of A. salmonicida a priority for developing effective control strategies.
The virulence of A. salmonicida is multifactorial, with several key pathogenic mechanisms identified. Among these, the Type III Secretion System (TTSS) represents one of the primary virulence factors . Research has demonstrated that expression of TTSS proteins in A. salmonicida is temperature-dependent, with induction occurring at 28°C but not at the bacterium's more natural growth temperature of 17°C . This temperature-induced up-regulation occurs rapidly, within 30 minutes of a growth temperature increase from 16°C to 28°C, suggesting sophisticated regulatory mechanisms controlling virulence factor expression.
The ArnE protein, as a probable flippase subunit involved in lipopolysaccharide modification, likely plays a significant role in bacterial adaptation to environmental stresses, particularly those related to antimicrobial exposure. In Gram-negative bacteria, modifications to the lipopolysaccharide layer often contribute to resistance against antimicrobial peptides and other host defense mechanisms.
The 4-amino-4-deoxy-L-arabinose modification of lipopolysaccharide represents a well-documented mechanism of resistance to cationic antimicrobial peptides in various Gram-negative bacteria. This modification reduces the negative charge of the bacterial outer membrane, thereby decreasing the electrostatic attraction of positively charged antimicrobial peptides to the bacterial surface.
Recent research has identified significant antigenic differences among Aeromonas salmonicida isolates, with variations in outer membrane protein and lipopolysaccharide profiles suggesting profound changes at the membrane structure level . While these studies specifically focused on the VapA virulence factor rather than ArnE, they highlight the importance of membrane composition in bacterial pathogenesis and host immune response evasion. The ArnE protein, through its role in LPS modification, may contribute to these antigenic variations and consequently influence host-pathogen interactions.
The recombinant production of ArnE protein enables detailed investigation of its structure, function, and potential as a therapeutic target. As indicated in available commercial information, the protein can be produced in various expression systems, including E. coli, yeast, baculovirus, or mammalian cells . This versatility allows researchers to optimize production based on specific experimental requirements.
The selection of an appropriate expression system for recombinant ArnE production depends on several factors, including desired yield, post-translational modifications, and functional requirements. Table 1 summarizes the comparative advantages of different expression systems for membrane protein production:
| Expression System | Advantages | Limitations | Suitability for ArnE Production |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | Limited post-translational modifications | Good for initial structural studies |
| Yeast | Eukaryotic post-translational processing, moderate yield | More complex than bacterial systems | Suitable for functional studies |
| Baculovirus | High-level expression, complex modifications | Time-consuming, specialized equipment required | Excellent for detailed functional analyses |
| Mammalian Cell | Native-like modifications, proper folding | Expensive, lower yields | Best for interaction studies |
The choice of expression system significantly impacts the quality and characteristics of the recombinant protein, particularly for membrane proteins like ArnE that require proper folding and membrane integration for functional analysis.
Recombinant ArnE protein serves several important research applications:
Structure-function studies to elucidate the mechanism of flippase activity
Development of inhibitors targeting the LPS modification pathway
Investigation of antimicrobial resistance mechanisms in Aeromonas salmonicida
Immunological studies examining bacterial membrane antigen recognition
Vaccine development research for fish furunculosis prevention
These applications highlight the significance of this protein in both basic science and applied research contexts. The specific focus on Aeromonas salmonicida makes this research particularly relevant to aquaculture and fish health management.
The high degree of conservation of this pathway across diverse Gram-negative bacteria suggests functional importance in bacterial survival and adaptation. In related bacterial species, mutations in the arn operon often result in increased susceptibility to antimicrobial peptides and certain antibiotics, underscoring the role of this pathway in antimicrobial resistance.
Related bacterial species, such as Salmonella paratyphi A, also possess homologous ArnE proteins with similar predicted functions . These homologous proteins provide valuable comparative models for understanding the function of the Aeromonas salmonicida ArnE protein through evolutionary and functional conservation analysis.
The modification of lipopolysaccharide through pathways involving the ArnE protein has significant implications for bacterial pathogenesis and antimicrobial resistance. In Aeromonas salmonicida, the ability to modify membrane structures may contribute to virulence through multiple mechanisms:
Enhanced resistance to host antimicrobial peptides
Altered recognition by host immune receptors
Increased survival within host environments
Modified biofilm formation capabilities
Potential interference with antibiotic binding or penetration
Recent research has identified that A. salmonicida isolates can display major antigenic differences, with some strains lacking established virulence factors like VapA while still causing disease . This suggests complex adaptability in virulence mechanisms, potentially involving alternative pathways such as those related to membrane modification through proteins like ArnE.
The temperature-dependent expression of virulence factors in A. salmonicida, as demonstrated for the Type III Secretion System , suggests sophisticated regulatory mechanisms responsive to environmental cues. While specific data on ArnE regulation is not available in the search results, it is reasonable to hypothesize that similar environmental responsive mechanisms may regulate the expression of membrane modification systems involving ArnE.
The observed induction of TTSS expression at higher temperatures (28°C) but not at the bacterium's natural growth temperature (17°C) suggests adaptation to specific host or environmental conditions . Similar regulatory patterns might apply to LPS modification systems, potentially contributing to bacterial survival across various environmental niches.
KEGG: asa:ASA_3312
STRING: 382245.ASA_3312
The ArnE protein in Aeromonas salmonicida functions as a subunit of the 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase complex. This membrane protein plays a crucial role in lipid trafficking across bacterial membranes, specifically facilitating the translocation of 4-amino-4-deoxy-L-arabinose-modified lipids. The protein's function is particularly significant as A. salmonicida is recognized as one of the oldest known fish pathogens with endemic status worldwide in both freshwater and marine environments .
The flippase activity of ArnE contributes to cell membrane integrity and potentially to antimicrobial resistance mechanisms. Structurally, ArnE belongs to a class of integral membrane proteins that typically contain multiple transmembrane domains arranged to form a pore or channel through which specific lipid substrates can be transported between membrane leaflets.
Based on established protocols for similar bacterial membrane proteins, E. coli-based expression systems offer significant advantages for recombinant ArnE production. A recommended approach utilizes expression vectors containing inducible promoters, similar to the aTc-inducible system described for other membrane proteins . The expression protocol should incorporate the following methodology:
Transform the expression construct into an appropriate E. coli strain (BL21 or derivatives)
Culture transformants to mid-log phase (OD₆₀₀ of approximately 0.8)
Induce protein expression with an appropriate inducer (e.g., 0.2 mg/liter aTc)
Continue cultivation at reduced temperature (20-22°C) for 15-18 hours to facilitate proper protein folding
Harvest cells by centrifugation (5,000 × g for 10 minutes at 4°C)
This approach minimizes the formation of inclusion bodies and enhances the yield of correctly folded membrane protein. Temperature optimization is particularly critical for membrane proteins like ArnE to ensure proper insertion into the bacterial membrane during expression.
Purification of recombinant ArnE requires specialized approaches due to its membrane-associated nature. The following multi-step purification strategy has proven effective for similar membrane proteins:
Resuspend harvested cells in an appropriate buffer (e.g., 50 mM sodium phosphate pH 8.0, 150 mM NaCl, 15% glycerol)
Lyse cells using mechanical disruption (French pressure cell at 1,000 lb/in²)
Remove intact cells and debris by low-speed centrifugation (10,000 × g for 10 minutes)
Isolate membrane fractions by ultracentrifugation (125,000 × g for 2 hours)
Solubilize membrane proteins using gentle detergents (0.5% w/v dodecyl maltoside)
Remove insoluble material by a second ultracentrifugation step
Perform immobilized metal affinity chromatography (IMAC) for His-tagged ArnE
This protocol can be further optimized by incorporating size exclusion chromatography as a polishing step to remove aggregates and achieve higher homogeneity of the purified protein.
Comprehensive spectroscopic characterization of recombinant ArnE provides critical insights into its structural properties and cofactor composition. The following methodological approach is recommended:
UV-Visible Spectroscopy: Record absorption spectra of purified ArnE using a photodiode array photometer or UV-visible spectrophotometer in a 1-cm-path-length quartz cuvette . Analyze the spectra between 250-600 nm to identify characteristic absorption peaks that might indicate the presence of prosthetic groups or cofactors.
Fluorescence Spectroscopy: Utilize intrinsic protein fluorescence from aromatic residues (excitation at 280 nm) to assess protein folding and stability under various conditions.
Circular Dichroism (CD): Apply far-UV CD (190-250 nm) to determine secondary structure composition and near-UV CD (250-350 nm) to evaluate tertiary structure integrity.
FTIR Spectroscopy: Employ FTIR to analyze specific structural elements, particularly helpful for membrane proteins to assess transmembrane domain organization.
For prosthetic group identification, implement a denaturation protocol using 0.2% SDS followed by spectroscopic analysis of the released cofactor . This approach allows discrimination between covalently and non-covalently bound prosthetic groups by comparing spectra before and after protein denaturation.
Investigation of ArnE's contribution to antibiotic resistance mechanisms requires multiple complementary approaches:
Gene Deletion Studies: Create ΔarnE knockout strains of A. salmonicida and evaluate changes in minimum inhibitory concentrations (MICs) against a panel of antibiotics, particularly cationic antimicrobial peptides.
Lipid Modification Analysis: Quantify 4-amino-4-deoxy-L-arabinose incorporation into lipopolysaccharide (LPS) in wild-type versus ΔarnE strains using mass spectrometry techniques.
Membrane Permeability Assays: Assess changes in membrane permeability using fluorescent dyes (e.g., propidium iodide, SYTOX Green) that penetrate cells with compromised membranes.
Recombinant Expression for Complementation: Express recombinant ArnE in knockout strains to confirm phenotype restoration, utilizing methods similar to those developed for recombinant adenovirus expression systems in A. salmonicida .
The table below summarizes expected outcomes from these experiments:
| Experimental Approach | Wild-type A. salmonicida | ΔarnE Mutant | Complemented Strain |
|---|---|---|---|
| Polymyxin B MIC (μg/ml) | High (>8) | Low (<2) | Restored (>6) |
| 4-amino-4-deoxy-L-arabinose in LPS | Present | Reduced/Absent | Restored |
| Membrane integrity | Intact | Compromised | Restored |
| Growth in high salt media | Normal | Impaired | Normal |
Structural characterization of ArnE presents significant challenges due to its membrane-embedded nature. A multi-technique approach offers the best strategy:
X-ray Crystallography: Implement specialized crystallization techniques for membrane proteins including:
Lipidic cubic phase crystallization
Detergent screening (using a minimum of 10 different detergents)
Addition of lipids to stabilize the protein during crystallization
Use of antibody fragments to increase polar surface area
Cryo-Electron Microscopy: For high-resolution structural determination without crystallization:
Prepare proteoliposomes or nanodiscs containing purified ArnE
Optimize freezing conditions to minimize ice crystal formation
Collect images using direct electron detectors
Perform 3D reconstruction using single-particle analysis
Molecular Dynamics Simulations: Complement experimental data with computational approaches:
Construct homology models based on related flippase structures
Embed models in simulated lipid bilayers
Perform microsecond-scale simulations to assess conformational dynamics
Identify potential substrate interaction sites
These methods provide complementary information about ArnE structure, contributing to understanding its functional mechanism in lipid flipping across bacterial membranes.
Comparative analysis of ArnE across bacterial species provides evolutionary and functional insights. Methodological approaches include:
Sequence-Based Phylogenetic Analysis:
Perform multiple sequence alignments of ArnE homologs from diverse bacteria
Construct phylogenetic trees using maximum likelihood or Bayesian methods
Identify conserved regions that may indicate functional domains
Map species-specific variations to potential functional adaptations
Functional Complementation Studies:
Express A. salmonicida ArnE in heterologous bacterial systems lacking endogenous ArnE
Assess restoration of phenotypes including antimicrobial resistance
Quantify cross-species functional conservation through rescue efficiency
Structural Comparison:
Generate homology models of ArnE from different species
Overlay structures to identify conserved and variable regions
Correlate structural differences with host adaptation or pathogenicity
This comparative approach contextualizes A. salmonicida ArnE within the broader evolutionary landscape of bacterial flippase proteins and may identify unique features related to fish pathogenicity.
Understanding ArnE's role in host-pathogen dynamics requires investigation at molecular, cellular, and organism levels:
Ex Vivo Immune Cell Interaction Studies:
Isolate fish macrophages or neutrophils and challenge with wild-type and ΔarnE A. salmonicida
Quantify phagocytosis rates, respiratory burst activity, and cytokine production
Assess bacterial survival within phagocytes using confocal microscopy and viability assays
In Vivo Infection Models:
Recombinant Vaccine Development:
Previous studies with recombinant adenovirus vaccines against A. salmonicida demonstrate the feasibility of this approach, with vaccination resulting in 60% survival compared to 23.4-26.4% in control groups following challenge .
Membrane protein purification presents specific challenges requiring methodological refinements:
Protein Denaturation During Solubilization:
Implement a detergent screening protocol testing at least 12 different detergents at various concentrations
Utilize mild detergents like DDM (0.5% w/v) that balance extraction efficiency with protein stability
Add stabilizing agents like glycerol (15% v/v) to all buffers
Consider native nanodiscs or amphipols as alternatives to detergents
Low Expression Yields:
Optimize codon usage for expression host
Test multiple fusion tags (His, MBP, SUMO) to identify constructs with improved expression
Explore specialized E. coli strains developed for membrane protein expression
Consider cell-free expression systems with direct incorporation into liposomes
Protein Aggregation:
Implement a multi-step purification strategy incorporating size exclusion chromatography
Add specific lipids that stabilize the native structure
Utilize dynamic light scattering to monitor aggregation state
Optimize buffer conditions including pH, salt concentration, and additives
These approaches have been successful with similar membrane proteins and can be adapted specifically for recombinant ArnE from A. salmonicida.
Functional validation of purified ArnE requires specialized assays that assess its flippase activity:
Reconstitution in Proteoliposomes:
Incorporate purified ArnE into preformed liposomes using detergent-mediated reconstitution
Verify incorporation using freeze-fracture electron microscopy and protein quantification
Assess protein orientation using protease protection assays
Flippase Activity Assays:
Prepare proteoliposomes with fluorescently labeled phospholipid analogs
Monitor translocation of labeled lipids between membrane leaflets using fluorescence spectroscopy
Quantify flipping rates under various conditions (pH, temperature, ionic strength)
Substrate Binding Studies:
Synthesize photo-activatable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol analogs
Perform photolabeling experiments to identify substrate binding sites
Validate binding specificity through competition assays with unlabeled substrate
These functional assays provide critical information about the biochemical activity of recombinant ArnE and help establish structure-function relationships.
The strategic targeting of ArnE represents a promising approach for developing selective antimicrobials against A. salmonicida:
High-Throughput Inhibitor Screening:
Develop fluorescence-based assays suitable for screening compound libraries
Utilize recombinant ArnE in liposomes for functional inhibition assays
Prioritize compounds that specifically inhibit flippase activity
Structure-Based Drug Design:
Utilize structural models of ArnE to identify potential binding pockets
Perform in silico docking studies with virtual compound libraries
Design peptidomimetics that compete with natural substrates
Combination Therapy Approaches:
Evaluate synergistic effects between ArnE inhibitors and conventional antibiotics
Target multiple components of the lipid modification pathway simultaneously
Assess resistance development through serial passage experiments
Given A. salmonicida's significant economic impact on the salmon farming industry , development of novel therapeutics targeting ArnE could provide valuable alternatives to current treatment options.
Next-generation analytical approaches offer unprecedented insights into membrane protein dynamics:
Single-Molecule Tracking:
Express fluorescently tagged ArnE variants in live bacteria
Utilize super-resolution microscopy (PALM/STORM) to track individual molecules
Analyze diffusion patterns and interaction dynamics in native membranes
Label-Free Mass Spectrometry:
Apply hydrogen-deuterium exchange mass spectrometry to map conformational dynamics
Identify regions with differential solvent accessibility in various functional states
Determine protein-lipid interaction interfaces
Neutron Reflectometry:
Create biomimetic membranes containing reconstituted ArnE
Analyze membrane structure and thickness changes during substrate translocation
Provide nanometer-scale resolution of protein orientation within membranes
These techniques provide complementary data about the dynamic behavior of ArnE during its functional cycle, informing both basic understanding and applied antimicrobial development.